Ovarian cancer: what's new, where next?

In the last few years a number of important studies relating to the investigation and management of ovarian cancer have firmly established a pivotal role in management for CT. CT provides accurate staging information, identifying key sites of disease which influence the success of cytoreductive surgery. CT facilitates histological diagnosis from needle core biopsy when surgery is considered inappropriate. These studies have provided a strong evidence base for current practice but we are left with some uncertainties.